Fanconi Anaemia, Complementation Group R |
approved
|
617244 |
|
|
Fanconi Anaemia, Complementation Group S |
approved
|
617883 |
|
|
Fanconi Anaemia, Complementation Group T |
approved
|
616435 |
|
|
Feingold syndrome 1 (FGLDS1) |
approved
|
164280 |
|
|
Fetal Akinesia Deformation Sequence (Pena-Shokeir syndrome type 1) |
approved
|
208150 |
|
|
Fibrodysplasia Ossificans Progressiva (FOP) |
approved
|
135100 |
|
|
Focal Dermal Hypoplasia (FDH) |
approved
|
305600 |
|
|
Focal Segmental Glomerulosclerosis 7 (FSGS7) |
approved
|
616002 |
|
|
Focal Segmental Glomerulosclerosis Type 1 |
approved
|
603278 |
|
|
Focal Segmental Glomerulosclerosis Type 2 |
approved
|
603965 |
|
|
Focal Segmental Glomerulosclerosis Type 5 |
approved
|
613237 |
|
|
Focal Segmental Glomerulosclerosis Type 6 |
approved
|
614131 |
|
|
Focal Segmental Glomerulosclerosis Type 8 |
approved
|
615032 |
|
|
Focal Segmental Glomerulosclerosis Type 9 |
approved
|
616220 |
|
|
Fontaine Progeroid Syndrome (FPS) |
approved
|
612289 |
|
|
Fragile X Syndrome (FRAX) |
approved
|
300624 |
|
Fragile XE syndrome (FRAXE) |
approved
|
309548 |
|
|
Fraser Syndrome |
approved
|
219000 |
|
|
Fraser Syndrome 2 (FRASRS2) |
approved
|
617666 |
|
|
Fraser Syndrome 3 (FRASRS3) |
approved
|
617667 |
|
|